EndoChoice (GI) Misses Q1 EPS by 13c

EndoChoice (NYSE: GI) reported Q1 EPS of ($0.68), $0.13 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $18.34 million.

GUIDANCE:

EndoChoice sees FY2016 EPS of ($2.01)-($1.95), versus the consensus of ($1.99). EndoChoice sees FY2016 revenue of $86-93 million, versus the consensus of $88.1 million.

For earnings history and earnings-related data on EndoChoice (GI) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Jabil (JBL) Tops Q4 EPS by 34c, Beats on Revenue; Offers FY Guidance
• Onto Innovation gains on bullish RBC initiation citing advanced packaging growth